MAPK8 and cancer: The involvement of FoxO signaling in promoting the anti‐cancer effects of therapeutic agents often begins with the activation of their upstream regulators, namely the AMPK and JNK proteins (Farhan et al. 2017; Wang et al. 2014b), which were also noted in our findings (Figure 3a; Figure A1).